Next Financial Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $0 | Hold |
150
| – | – | ﹤0.01% | 3030 |
|
|
2021
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 2714 |
|
|
2021
Q2 | $1K | Sell |
150
-385
| -72% | -$2.57K | ﹤0.01% | 2595 |
|
|
2021
Q1 | $2K | Sell |
535
-1,400
| -72% | -$5.23K | ﹤0.01% | 2351 |
|
|
2020
Q4 | $6K | Hold |
1,935
| – | – | ﹤0.01% | 1955 |
|
|
2020
Q3 | $6K | Buy |
+1,935
| New | +$6K | ﹤0.01% | 1807 |
|
|
2020
Q2 | – | Sell |
-1,935
| Closed | -$7K | – | 2019 |
|
|
2020
Q1 | $7K | Sell |
1,935
-1,598
| -45% | -$5.78K | ﹤0.01% | 1637 |
|
|
2019
Q4 | $21K | Buy |
3,533
+1,598
| +83% | +$9.5K | ﹤0.01% | 1520 |
|
|
2019
Q3 | $15K | Hold |
1,935
| – | – | ﹤0.01% | 1568 |
|
|
2019
Q2 | $26K | Buy |
1,935
+1,785
| +1,190% | +$24K | ﹤0.01% | 1379 |
|
|
2019
Q1 | $1K | Sell |
150
-2,161
| -94% | -$14.4K | ﹤0.01% | 1601 |
|
|
2018
Q4 | $7K | Buy |
2,311
+2,161
| +1,441% | +$6.55K | ﹤0.01% | 1467 |
|
|
2018
Q3 | $1K | Buy |
+150
| New | +$1K | ﹤0.01% | 1441 |
|
|
2017
Q4 | – | Sell |
-650
| Closed | -$6K | – | 1511 |
|
|
2017
Q3 | $6K | Buy |
650
+500
| +333% | +$4.62K | ﹤0.01% | 1391 |
|
|
2017
Q2 | $3K | Hold |
150
| – | – | ﹤0.01% | 1693 |
|
|
2017
Q1 | $3K | Buy |
+150
| New | +$3K | ﹤0.01% | 1649 |
|